Syros Pharmaceuticals Inc (NASDAQ:SYRS)
| 5.61 Delayed Data As of Jun 18 |  -0.01 / -0.18%Today’s Change | 4.75 Today|||52-Week Range 15.65 | -48.29% Year-to-Date |
Latest SYRS News | Press Releases
No recent news for Syros Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.62 |
| Today’s open | 5.68 |
| Day’s range | 5.45 - 5.67 |
| Volume | 52,035 |
| Average volume (3 months) | 1,151,313 |
| Market cap | $348.3M |
Data as of 4:00pm ET, 06/18/2021
Growth & Valuation
| Earnings growth (last year) | +2.70% |
| Earnings growth (this year) | +19.02% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +661.50% |
| P/E ratio | NM |
| Price/Sales | 33.11 |
| Price/Book | 3.50 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CRMDCorMedix Inc | -0.14 | -1.78% |
| SELBSelecta Biosciences ... | -0.25 | -5.03% |
| VTGNVistaGen Therapeutic... | +0.01 | +0.35% |
| PRTGPortage Biotech Inc | -3.81 | -8.90% |
Data as of 4:00pm ET, 06/18/2021
Financials
| Next reporting date | August 11, 2021 |
| EPS forecast (this quarter) | -$0.37 |
| Annual revenue (last year) | $15.1M |
| Annual profit (last year) | -$84.0M |
| Net profit margin | -556.80% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
